Department of Emergency, Chinese PLA Air Force General Hospital, Haidian District, Beijing, China.
Jinsong Sanatorium of Beijing Air Force, Beijing, China.
PLoS One. 2014 Feb 19;9(2):e89167. doi: 10.1371/journal.pone.0089167. eCollection 2014.
Several studies have investigated whether the polymorphism in the apolipoprotein A5 (APOA5) is associated with type 2 diabetes mellitus (T2DM) risk. However, those studies have produced inconsistent results. The purpose of this study was to investigate whether the APOA5 -1131T/C polymorphism (rs662799) confers significant susceptibility to T2DM using a meta-analysis.
PubMed, Embase, Web of Science, Cochrane database, CBMdisc, CNKI and Google Scholar were searched to get the genetic association studies. All statistical analyses were done with Stata 11.0.
A total of 19 studies included 4,767 T2DM cases and 10,370 controls (four studies involving 555 T2DM cases and 2958 controls were performed among Europeans and 15 studies involving 4212 T2DM cases and 7412 controls were performed among Asians) were combined showing significant association between the APOA5 -1131T/C polymorphism and T2DM risk (for C allele vs. T allele: OR = 1.28, 95% CI = 1.17-1.40, p<0.00001; for C/C vs. T/T: OR = 1.57, 95% CI = 1.35-1.83, p<0.00001; for C/C vs. T/C+T/T: OR = 1.36, 95% CI = 1.18-1.57, p<0.0001; for C/C+T/C vs. T/T: OR = 1.32, 95% CI = 1.16-1.51, p<0.0001). In the subgroup analysis by ethnicity, significant association was also found among Asians (for C allele vs. T allele: OR = 1.31, 95% CI = 1.22-1.40, p<0.00001; for C/C vs. T/T: OR = 1.61, 95% CI = 1.38-1.88, p<0.00001; for C/C vs. T/C+T/T: OR = 1.39, 95% CI = 1.20-1.61, p<0.0001; for C/C+T/C vs. T/T: OR = 1.42, 95% CI = 1.25-1.62, p<0.00001). However, no significant association was found between the APOA5 -1131T/C polymorphism and T2DM risk among Europeans.
The present meta-analysis suggests that the APOA5 -1131T/C polymorphism is associated with an increased T2DM risk in Asian population.
多项研究探讨了载脂蛋白 A5 (APOA5) 多态性是否与 2 型糖尿病 (T2DM) 风险相关。然而,这些研究结果并不一致。本研究旨在通过荟萃分析探讨 APOA5-1131T/C 多态性(rs662799)是否与 T2DM 的易感性显著相关。
检索PubMed、Embase、Web of Science、Cochrane 数据库、CBMdisc、CNKI 和 Google Scholar,以获取遗传关联研究。所有统计分析均使用 Stata 11.0 进行。
共纳入 19 项研究,包括 4767 例 T2DM 病例和 10370 例对照(4 项研究涉及 555 例 T2DM 病例和 2958 例对照,其中 4 项研究涉及欧洲人,15 项研究涉及 4212 例 T2DM 病例和 7412 例对照,其中 15 项研究涉及亚洲人),结果显示 APOA5-1131T/C 多态性与 T2DM 风险之间存在显著关联(对于 C 等位基因与 T 等位基因:OR=1.28,95%CI=1.17-1.40,p<0.00001;对于 C/C 与 T/T:OR=1.57,95%CI=1.35-1.83,p<0.00001;对于 C/C 与 T/C+T/T:OR=1.36,95%CI=1.18-1.57,p<0.0001;对于 C/C+T/C 与 T/T:OR=1.32,95%CI=1.16-1.51,p<0.0001)。按种族亚组分析,也发现亚洲人群中存在显著相关性(对于 C 等位基因与 T 等位基因:OR=1.31,95%CI=1.22-1.40,p<0.00001;对于 C/C 与 T/T:OR=1.61,95%CI=1.38-1.88,p<0.00001;对于 C/C 与 T/C+T/T:OR=1.39,95%CI=1.20-1.61,p<0.0001;对于 C/C+T/C 与 T/T:OR=1.42,95%CI=1.25-1.62,p<0.00001)。然而,在欧洲人群中,APOA5-1131T/C 多态性与 T2DM 风险之间无显著相关性。
本荟萃分析表明,APOA5-1131T/C 多态性与亚洲人群 T2DM 风险增加相关。